These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 8752999)
1. [TCR alpha beta + CD4- CD8- T cells among the peripheral blood mononuclear cells of myasthenia gravis patients]. Nagane Y; Utsugisawa K; Matsubara R; Yamagata M; Tohgi H No To Shinkei; 1996 Jul; 48(7):644-7. PubMed ID: 8752999 [TBL] [Abstract][Full Text] [Related]
2. Detailed characterization of gamma delta T cells within the organs in mice: classification into three groups. Sato K; Ohtsuka K; Watanabe H; Asakura H; Abo T Immunology; 1993 Nov; 80(3):380-7. PubMed ID: 8288314 [TBL] [Abstract][Full Text] [Related]
3. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis. Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972 [TBL] [Abstract][Full Text] [Related]
4. The T cell receptor in normal and inflamed human conjunctiva. Soukiasian SH; Rice B; Foster CS; Lee SJ Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):453-9. PubMed ID: 1531476 [TBL] [Abstract][Full Text] [Related]
5. Induction of human gamma delta T cells in myasthenia gravis thymus transplanted SCID mice. Iwata T; Inoue K; Kato T; Nishida T; Kinoshita H Osaka City Med J; 1999 Dec; 45(2):109-21. PubMed ID: 10730077 [TBL] [Abstract][Full Text] [Related]
6. Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen. Schulz RJ; Parkes A; Mizoguchi E; Bhan AK; Koyasu S J Immunol; 1996 Nov; 157(10):4379-89. PubMed ID: 8906813 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas. Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260 [TBL] [Abstract][Full Text] [Related]
8. Association of methotrexate treatment with a decrease of double negative (CD4-CD8-) and gamma/delta T cell levels in patients with juvenile rheumatoid arthritis. Massa M; de Benedetti F; Robbioni P; Ramenghi B; Albani S; Martini A J Rheumatol; 1993 Nov; 20(11):1944-8. PubMed ID: 8308783 [TBL] [Abstract][Full Text] [Related]
9. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma. Reinhardt C; Melms A Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443 [TBL] [Abstract][Full Text] [Related]
10. Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions. Cornfield DB; Gheith SM Cytometry B Clin Cytom; 2009 May; 76(3):213-7. PubMed ID: 18803280 [TBL] [Abstract][Full Text] [Related]
11. TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expression. Yrlid U; Petersson E; Dohlsten M; Hedlund G Cell Immunol; 1996 Nov; 173(2):287-94. PubMed ID: 8912889 [TBL] [Abstract][Full Text] [Related]
12. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides. Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512 [TBL] [Abstract][Full Text] [Related]
13. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis. Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882 [TBL] [Abstract][Full Text] [Related]
14. Effect of immunomodulatory treatment of multiple sclerosis on lymphocyte surface immunomarkers. MichaĆowska-Wender G; Losy J; Wender M; Januszkiewicz-Lewandowska D; Nowak J Pol J Pharmacol; 2003; 55(5):877-80. PubMed ID: 14704481 [TBL] [Abstract][Full Text] [Related]
15. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. Kawanishi Y; Passweg J; Drobyski WR; Rowlings P; Cook-Craig A; Casper J; Pietryga D; Garbrecht F; Camitta B; Horowitz M; Juckett M; Margolis D; Flomenberg N; Keever-Taylor CA Bone Marrow Transplant; 1997 Jun; 19(11):1069-77. PubMed ID: 9193748 [TBL] [Abstract][Full Text] [Related]
16. TCR gamma delta + T cells in peripheral blood of patients with adult Still's disease. Hoshino T; Ohta A; Nakao M; Ota T; Inokuchi T; Matsueda S; Gouhara R; Yamada A; Itoh K; Oizumi K J Rheumatol; 1996 Jan; 23(1):124-9. PubMed ID: 8838520 [TBL] [Abstract][Full Text] [Related]
17. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein. Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355 [TBL] [Abstract][Full Text] [Related]
18. T lymphocyte development in the absence of CD3 epsilon or CD3 gamma delta epsilon zeta. Wang B; Wang N; Whitehurst CE; She J; Chen J; Terhorst C J Immunol; 1999 Jan; 162(1):88-94. PubMed ID: 9886373 [TBL] [Abstract][Full Text] [Related]
19. [CD4+ alpha beta T cell and gamma delta T cell responses to BCG in patients with pulmonary tuberculosis--comparison with healthy controls]. Tsukaguchi K; Okamura H; Tokuyama T; Okamoto Y; Fu A; Yamamoto C; Nakaya M; Kobayashi A; Yoneda T; Narita N Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Dec; 35(12):1330-7. PubMed ID: 9567077 [TBL] [Abstract][Full Text] [Related]
20. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients. Navaneetham D; Penn AS; Howard JF; Conti-Fine BM J Autoimmun; 1998 Dec; 11(6):621-33. PubMed ID: 9878084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]